Futuximab

Futuximab is a chimeric monoclonal antibody targeting non-overlapping epitopes on EGFR. Futuximab has antineoplastic activity[1].

Product Specifications

CAS Number

[1310460-85-5]

UNSPSC

12352203

Target

EGFR

Type

Inhibitory Antibodies

Related Pathways

JAK/STAT Signaling; Protein Tyrosine Kinase/RTK

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/futuximab.html

Purity

98.09

Solubility

10 mM in DMSO

Smiles

[Futuximab]

Molecular Weight

(146.28 kDa)

References & Citations

[1]Stephen T Keir, et al. Sym004-induced EGFR elimination is associated with profound anti-tumor activity in EGFRvIII patient-derived glioblastoma models. J Neurooncol. 2018 Jul;138 (3) :489-498.

Shipping Conditions

Dry Ice

Storage Conditions

Store at -80°C for 2 years

Scientific Category

Inhibitory Antibodies

Clinical Information

Phase 2

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBP2-34494-25ul 25 µL

Mouse Monoclonal Von Willebrand Factor Antibody (CL1957)

Ask

View Details

TA811528 100 µL

CD14 Mouse Monoclonal Antibody [Clone ID: OTI12C8]

Ask

View Details

FAB1246JF525 0.5 mL

Rat Monoclonal 4-1BB Ligand/TNFSF9 Antibody (203942) [Janelia Fluor 525]

Ask

View Details

CF801057 100 µg

ALK Rat Monoclonal Antibody [Clone ID: OTI3H7]

Ask

View Details